RDY Historical Balance Sheet
RDY Stock | USD 13.99 0.31 2.17% |
Trend analysis of Dr Reddys Laboratories balance sheet accounts such as Retained Earnings of 279.2 B, Accounts Payable of 14.3 B, Cash of 13.6 B or Other Assets of 8.6 B provides information on Dr Reddys' total assets, liabilities, and equity, which is the actual value of Dr Reddys Laboratories to its prevalent stockholders. By breaking down trends over time using Dr Reddys balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Dr Reddys Laboratories latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Dr Reddys Laboratories is a good buy for the upcoming year.
Dr Reddys Inventory |
|
RDY |
About RDY Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Dr Reddys Laboratories at a specified time, usually calculated after every quarter, six months, or one year. Dr Reddys Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Dr Reddys and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which RDY currently owns. An asset can also be divided into two categories, current and non-current.
Dr Reddys Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Dr Reddys assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Dr Reddys Laboratories books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Dr Reddys balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Dr Reddys Laboratories are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Net Tangible Assets
The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.Most accounts from Dr Reddys' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Dr Reddys Laboratories current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Dr Reddys Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. At this time, Dr Reddys' Cash And Short Term Investments are fairly stable compared to the past year. Good Will is likely to rise to about 6.5 B in 2024, whereas Total Assets are likely to drop slightly above 214.9 B in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 48.3B | 53.5B | 58.1B | 61.0B | Total Assets | 296.7B | 322.9B | 387.5B | 214.9B |
Dr Reddys balance sheet Correlations
Click cells to compare fundamentals
Dr Reddys Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Dr Reddys balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 232.2B | 265.5B | 296.7B | 322.9B | 387.5B | 214.9B | |
Other Current Liab | 39.4B | 45.3B | 48.3B | 53.5B | 58.1B | 61.0B | |
Total Current Liabilities | 72.8B | 81.5B | 97.8B | 85.7B | 96.0B | 69.8B | |
Total Stockholder Equity | 155.0B | 175.0B | 190.5B | 232.9B | 280.6B | 294.6B | |
Retained Earnings | 144.2B | 157.9B | 175.7B | 215.6B | 265.9B | 279.2B | |
Accounts Payable | 10.7B | 12.7B | 16.0B | 17.9B | 21.5B | 14.3B | |
Cash | 2.1B | 14.8B | 14.9B | 5.8B | 7.1B | 13.6B | |
Other Assets | 14.8B | 11.6B | 13.7B | 7.1B | 8.2B | 8.6B | |
Long Term Debt | 21.4B | 0.0 | 6.3B | 5.7B | 3.8B | 3.5B | |
Short Term Investments | 23.7B | 19.7B | 29.5B | 61.0B | 74.4B | 78.1B | |
Inventory | 35.1B | 45.4B | 50.9B | 48.7B | 63.6B | 32.0B | |
Total Liab | 77.3B | 90.5B | 106.1B | 90.0B | 107.0B | 89.6B | |
Intangible Assets | 27.7B | 35.6B | 27.2B | 30.7B | 37.0B | 24.7B | |
Property Plant Equipment | 52.3B | 57.1B | 62.2B | 66.3B | 76.2B | 80.1B | |
Short Long Term Debt Total | 22.1B | 30.3B | 33.8B | 13.5B | 20.0B | 19.0B | |
Other Liab | 3.5B | 3.1B | 2.7B | 2.5B | 2.9B | 3.1B | |
Property Plant And Equipment Net | 52.3B | 57.1B | 62.2B | 56.5B | 76.9B | 55.3B | |
Current Deferred Revenue | 1.9B | 2.0B | 2.6B | 2.0B | 1.4B | 1.4B | |
Net Debt | 20.0B | 15.5B | 19.0B | 7.7B | 12.9B | 12.3B | |
Non Current Assets Total | 101.9B | 117.2B | 115.5B | 118.6B | 139.5B | 98.4B | |
Non Currrent Assets Other | 2.6B | 952M | 948M | 12.7B | 16.1B | 16.9B | |
Cash And Short Term Investments | 25.7B | 34.6B | 44.4B | 66.7B | 81.5B | 85.5B | |
Net Receivables | 61.8B | 49.6B | 66.8B | 72.5B | 80.3B | 48.4B | |
Good Will | 4.0B | 4.6B | 4.4B | 5.5B | 4.3B | 6.5B | |
Common Stock Shares Outstanding | 166.1M | 166.3M | 166.3M | 166.4M | 166.7M | 175.5M | |
Liabilities And Stockholders Equity | 232.2B | 265.5B | 296.7B | 322.9B | 387.5B | 223.8B | |
Non Current Liabilities Total | 4.4B | 9.0B | 8.3B | 4.3B | 10.9B | 20.2B | |
Other Current Assets | 5.8B | 18.6B | 19.8B | 21.3B | 22.7B | 23.9B | |
Other Stockholder Equity | 7.5B | 8.2B | 8.4B | 10.3B | 1.7B | 1.6B | |
Total Current Assets | 130.4B | 148.2B | 181.1B | 204.3B | 248.0B | 127.1B | |
Accumulated Other Comprehensive Income | 2.4B | 1.3B | 1.1B | 1.3B | 4.0B | 3.8B | |
Short Term Debt | 20.8B | 24.0B | 28.1B | 12.2B | 14.0B | 27.0B | |
Property Plant And Equipment Gross | 52.3B | 57.1B | 142.0B | 152.3B | 170.1B | 161.6B | |
Net Tangible Assets | 91.9B | 123.3B | 134.8B | 158.9B | 182.7B | 102.9B | |
Long Term Investments | 3.1B | 8.3B | 8.0B | 6.1B | 5.3B | 4.6B | |
Short Long Term Debt | 20.3B | 24.0B | 28.1B | 12.2B | 12.7B | 16.6B | |
Long Term Debt Total | 1.3B | 6.3B | 5.7B | 1.3B | 1.2B | 1.1B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for RDY Stock Analysis
When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.